SHA:688189 Revenue

Hunan Nucien Pharmaceutical had revenue of 21.31M CNY in the quarter ending September 30, 2025, a decrease of -40.45%. This brings the company's revenue in the last twelve months to 95.33M, down -76.70% year-over-year. In the year 2024, Hunan Nucien Pharmaceutical had annual revenue of 263.28M, down -63.44%.

Revenue (ttm)

95.33M

Revenue Growth

-76.70%

P/S Ratio

24.25

Revenue / Employee

260.46K

Employees

319

Market Cap

2.31B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	263.28M	-456.78M	-63.44%
Dec 31, 2023	720.06M	21.24M	3.04%
Dec 31, 2022	698.83M	-44.83M	-6.03%
Dec 31, 2021	743.66M	-285.48M	-27.74%
Dec 31, 2020	1.03B	14.92M	1.47%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shandong Sito Bio-technology	954.76M
Zhejiang East Asia Pharmaceutical	831.56M
Guiyang Xintian Pharmaceutical	755.34M
Jilin Jian Yisheng Pharmaceutical	639.10M
Hubei Goto Biopharm	626.28M
Jiangsu Sihuan Bioengineering	341.90M
Sailong Pharmaceutical Group	244.84M
Shanghai Serum Bio-Technology	196.76M

Revenue Rankings